Skip to main content
. 2015 Sep 22;13:151. doi: 10.1186/s12955-015-0342-1

Table 2.

Characteristics of patients’ QoL change patterns

Pattern 1* Pattern 2 Pattern 3 Pattern 4
graphic file with name 12955_2015_342_Figa_HTML.gif graphic file with name 12955_2015_342_Figb_HTML.gif graphic file with name 12955_2015_342_Figc_HTML.gif graphic file with name 12955_2015_342_Figd_HTML.gif Pa
Number of patients 24 171 78 143
Gender
 Men n(%) 15 (63) 128 (75) 58 (74) 108 (76) 0.596
Age (years)
 md ± inqb 63 ± 17 61 ± 15 65 ± 19 60 ± 17 0.370
Performance status at D0
 =0-1c n (%) 20 (83.3) 151 (88.3) 56 (71.8) 126 (88.1) 0.004
 =2 n (%) 4 (16.7) 20 (11.7) 22 (28.2) 17 (11.9)
Type of tumor
 Diffuse n (%) 7 (29.2) 33(19.3) 22(28.2) 35(24.5) 0.369
Randomization arm
 FOLFIRI n (%) 5 (20.8) 93 (54.4) 35 (44.9) 74 (51.8) 0.015
Quality of life Score
 Score7-Score1 (p**) 10.7 (0.520) −13.4 (0.013) −62.7 (0.038) −67.6 (<10−3)
SAEd
 n(%) 13 (54) 67 (39) 62 (81) 86 (60) <10−3
TTFe (weeks)
 md ± inq 15 ± 18 30 ± 24 4 ± 7 20 ± 12 <10−3
Death
 n(%) 3 (13) 18 (11) 78 (100) 131 (92) <10−3

a : p for significance

b :median ± inter-quartile range

c Performance status

0 = Fully active, able to carry on all pre-disease performance / 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature

2 = Ambulatory and capable of all selfcare but unable to carry out any work activities. Up and about more than 50 % of waking hours

d Serious adverse events

e time to therapeutic failure of the first-line treatment

* x-axis: time (unit = weeks) and y-axis: the physical functioning scale scores (range [0–100])

** p for significance of the slope predicted by a linear model